Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0.542. It has been cited 8 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.213
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institute of Allergy and Infectious Diseases
Grant: R01AI46095
NIAID NIH HHS
Grant: R01 AI146095
World Health Organization
Grant: 001
National Institutes of Health
Grant: 1R43AI046095-01
COHERENCE NEAR-INFRARED UREA BREATH TEST ANALYZER
NIH
Global Fund to Fight AIDS, Tuberculosis, and Malaria
NIH
Global Fund to Fight AIDS, Tuberculosis, and Malaria
FWCI
2.44
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals